EUVIMEDEUVIMED entdecken
Open Access

Sub-analysis of perfusion balloon predilatation with intracoronary nicorandil vs. distal protection for acute coronary syndrome: A comparative evaluation

Masataka Yoshinaga, Takashi Muramatsu, Takashi Uwatoko, Akane Miyazaki, Takuo Toriya, Yuji Matsuwaki, Masato Ishikawa, Yuko Ukai, Yohei Kobayashi, Katsuyoshi Ito, Hideaki Ota, Yoshihiro Sobue und 2 weitere

Fujita Medical Journal · 2026-02 · 12 (1) · 50-59

DOI: 10.20407/fmj.2025-009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fujita Medical Journal, 2026-02. Verfasst von Masataka Yoshinaga und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Slow-flow or no-reflow events occur as a complication during percutaneous coronary intervention for acute coronary syndrome (ACS). A previous study demonstrated that prolonged perfusion balloon (PB) predilatation combined with intracoronary administration of nicorandil attenuates this phenomenon. This subanalysis compared the efficacy of the PB approach with that of conventional distal protection (DP).

Methods

The study had a retrospective, single-center, observational design and included patients who underwent percutaneous coronary intervention for ACS between April 2020 and April 2022. The patients were divided into a PB group and a DP group. The PB group underwent thrombus aspiration, followed by 3 minutes of predilatation using the Ryusei® PB, with simultaneous intracoronary administration of nicorandil 2 mg without a DP device and subsequent placement of a drug-eluting stent. The DP group underwent direct stenting or predilatation with a standard balloon combined with a DP device without a PB. Primary endpoints included the incidence of slow-flow or no-reflow events.

Results

Sixty-four patients with ACS were enrolled (PB group, n=32; DP group, n=32). The incidence of slow-flow or no-reflow events was significantly lower in the PB group (3.1% vs. 46.8%, p

Schlagwörter

Stichwörter der Autor:innen

Acute coronary syndromeComplicationPercutaneous coronary interventionPerfusion balloonSlow-flow

Autor:innen und Institutionen

  • Department of Cardiology, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
  • Department of Cardiology, Cardiovascular Center, Fujita Health University Hospital, Toyoake, Aichi, Japan.
  • Faculty of Nursing, Fujita Health University Hospital, Toyoake, Aichi, Japan.
  • Department of Radiology, Fujita Health University Hospital, Toyoake, Aichi, Japan.

Zitieren

APA

Yoshinaga, M., Muramatsu, T., Uwatoko, T., Miyazaki, A., Toriya, T., Matsuwaki, Y., Ishikawa, M., Ukai, Y., Kobayashi, Y., Ito, K., Ota, H., Sobue, Y., Watanabe, E., & Izawa, H. (2026). Sub-analysis of perfusion balloon predilatation with intracoronary nicorandil vs. distal protection for acute coronary syndrome: A comparative evaluation. Fujita Medical Journal, 12(1), 50-59. https://doi.org/10.20407/fmj.2025-009

Vancouver

Yoshinaga M, Muramatsu T, Uwatoko T, Miyazaki A, Toriya T, Matsuwaki Y, et al. Sub-analysis of perfusion balloon predilatation with intracoronary nicorandil vs. distal protection for acute coronary syndrome: A comparative evaluation. Fujita Medical Journal. 2026;12(1):50-59. doi:10.20407/fmj.2025-009

BibTeX
@article{Yoshinaga2026,
  author = {Yoshinaga, Masataka and Muramatsu, Takashi and Uwatoko, Takashi and Miyazaki, Akane and Toriya, Takuo and Matsuwaki, Yuji and Ishikawa, Masato and Ukai, Yuko and Kobayashi, Yohei and Ito, Katsuyoshi and Ota, Hideaki and Sobue, Yoshihiro and Watanabe, Eiichi and Izawa, Hideo},
  title = {Sub-analysis of perfusion balloon predilatation with intracoronary nicorandil vs. distal protection for acute coronary syndrome: A comparative evaluation},
  journal = {Fujita Medical Journal},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {50--59},
  doi = {10.20407/fmj.2025-009}
}
Kostenlos starten →